Taxane resistance in metastatic breast cancer and novel microtubule-targeting agents / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 622-624, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-497590
ABSTRACT
The development of primary or acquired taxane resistance inevitably becomes to be the main problem.Ixabepilone is effective in metastatic breast cancer (MBC) patients including those heavily pretreated or resistant to taxanes.Eribulin has been used for the treatment of MBC patients who have received at least two prior chemotherapy regimens.New microtubule-targeting agents are promising to be effective options for patients progressing after standard taxane-containing chemotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS